1984
DOI: 10.1007/bf00328096
|View full text |Cite
|
Sign up to set email alerts
|

Assay evaluability of drug testing systems determined with human renal carcinoma cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1986
1986
1997
1997

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…The three tumor lines, RC-8, RC-9, and NC-65, have all been derived from patients with renal cell carcinomas in the advanced stage and have been maintained in nude mice (12)(13)(14)(15). During subsequent passages, no alterations occurred in the growth kinetics, histology, or immunohistochemistry of the tumors.…”
Section: Tumor Linesmentioning
confidence: 99%
“…The three tumor lines, RC-8, RC-9, and NC-65, have all been derived from patients with renal cell carcinomas in the advanced stage and have been maintained in nude mice (12)(13)(14)(15). During subsequent passages, no alterations occurred in the growth kinetics, histology, or immunohistochemistry of the tumors.…”
Section: Tumor Linesmentioning
confidence: 99%
“…Therefore, we suspect that biological differences in the subfractions of RCT may give rise to differences in behavior of tumor metastases, and undoubtedly have consequences for chemotherapy. The development of model systems for further cell biological and experimental investigations of RCT has led to the establishment of 4 human renal-cell xenografts in nude mice (Kurth et al, 1984) and of a tumor line from a rat RCT in Wistar Lewis rats (deVere White et al, 1980). In this study, we present findings on the 2-parameter FCM analysis of cellular DNA and 'In these cases labelling with either cytokeratin or vimentin antibodies resulted in the detection of an aneuploid peak not seen without labelling.…”
mentioning
confidence: 99%
“…Since IFN-alpha appears to be a potential active antitumor agent in patients with RCC [20,21] and TNF also shows very clear in vitro cytostatic and cytolytic effects on human renal cell carcinoma cell lines, we decided to test the in vitro antiproliferative effects of human recombinant IFN-alpha and -gamma as well as human recombinant TNF on two RCC tumor lines-NC-65 and RC-43 [22,23].…”
Section: Introductionmentioning
confidence: 99%